Scarica l'app Stockscreener
25.00
0.28%
-0.07
Precedente Chiudi:
$25.07
Aprire:
$25.06
Volume 24 ore:
875.84K
Relative Volume:
0.24
Capitalizzazione di mercato:
$2.00B
Reddito:
-
Utile/perdita netta:
$-96.66M
Rapporto P/E:
-11.63
EPS:
-2.15
Flusso di cassa netto:
$-83.73M
1 W Prestazione:
-8.93%
1M Prestazione:
-11.72%
6M Prestazione:
+486.85%
1 anno Prestazione:
+328.82%
Intervallo 1D:
$24.87
$25.76
Intervallo di 1 settimana:
$24.87
$27.66
Portata 52W:
$2.86
$36.26
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Nome
Olema Pharmaceuticals Inc
Settore
Industria
Telefono
(415) 651-3316
Indirizzo
780 BRANNAN STREET, SAN FRANCISCO
Confronta OLMA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
25.00 | 2.01B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
453.36 | 115.12B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.87 | 81.34B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.65 | 52.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
840.95 | 51.59B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
174.04 | 37.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-12 | Reiterato | Citigroup | Buy |
| 2024-04-02 | Iniziato | Goldman | Buy |
| 2024-01-30 | Iniziato | Citigroup | Buy |
| 2023-07-21 | Iniziato | Oppenheimer | Outperform |
| 2023-05-05 | Iniziato | CapitalOne | Overweight |
| 2023-02-22 | Iniziato | Credit Suisse | Outperform |
| 2022-07-06 | Ripresa | Canaccord Genuity | Buy |
| 2022-06-09 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Iniziato | H.C. Wainwright | Neutral |
| 2021-12-07 | Ripresa | Cowen | Outperform |
| 2020-12-14 | Iniziato | Canaccord Genuity | Buy |
| 2020-12-14 | Iniziato | Cowen | Outperform |
| 2020-12-14 | Iniziato | JP Morgan | Overweight |
| 2020-12-14 | Iniziato | Jefferies | Buy |
Mostra tutto
Olema Pharmaceuticals Inc Borsa (OLMA) Ultime notizie
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 2,881 Shares of Stock - MarketBeat
Olema Pharmaceuticals director Harmon sells $82,194 in stock - Investing.com India
Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open - ts2.tech
Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday - ts2.tech
Will Olema Pharmaceuticals’ (OLMA) Index Debut Quietly Redefine Its Standing Among Biotech Investors? - simplywall.st
Olema: 'Strong Buy' Maintained On OPERA-02 Trial Initiation & Additional Shots On Goal - Seeking Alpha
Olema Pharmaceuticals Insider Sold Shares Worth $1,553,544, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,873,109, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,530,148, According to a Recent SEC Filing - marketscreener.com
Olema pharma chief medical officer sells shares for $7.5m By Investing.com - Investing.com South Africa
Olema Pharmaceuticals (NASDAQ:OLMA) Insider Naseem Zojwalla Sells 70,000 Shares of Stock - MarketBeat
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Insider Sells $2,752,418.94 in Stock - MarketBeat
David Myles Sells 51,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals ch. discov. Myles C. sells $1.55m in stock - Investing.com Australia
Olema Pharmaceuticals ch. discov. Myles C. sells $1.55m in stock By Investing.com - Investing.com South Africa
Olema pharma director Clark sells $7.87 million in shares - Investing.com India
Olema pharma director Clark sells $7.87 million in shares By Investing.com - Investing.com UK
Olema pharma chief medical officer sells shares for $7.5m - Investing.com
Olema Pharmaceuticals (OLMA): Reassessing Valuation After S&P Biotechnology Select Industry Index Inclusion - Sahm
Roche boosts Olema as breast cancer therapy succeeds in late-stage trial - MSN
Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index - marketscreener.com
Olema Pharmaceuticals (OLMA) price target increased by 25.00% to 46.54 - MSN
How Olema Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 AllTime Highs & Short-Term Trading Opportunity Alerts - Улправда
Aug Rallies: Will Olema Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Gainers & Precise Swing Trade Entry Alerts - Улправда
Why Olema Pharmaceuticals Inc. stock is favored by pension fundsJuly 2025 Closing Moves & Verified Momentum Stock Watchlist - Улправда
Why Olema Pharmaceuticals Inc. stock is popular among millennialsJuly 2025 Intraday Action & Stock Portfolio Risk Control - Улправда
Officer Myles Files To Sell 51,000 Of Olema Pharmaceuticals Inc [OLMA] - TradingView — Track All Markets
Olema Pharmaceuticals (NASDAQ: OLMA) Stock: Latest News, Analyst Forecasts, and What’s Driving the Volatility on December 19, 2025 - ts2.tech
Is Olema Pharmaceuticals Inc. stock positioned well for digital economyQuarterly Trade Report & Detailed Earnings Play Strategies - DonanımHaber
Will Olema Pharmaceuticals Inc. stock pay special dividendsJuly 2025 Big Picture & Daily Technical Stock Forecast Reports - Улправда
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 3.5%Time to Sell? - MarketBeat
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Olema Pharmaceuticals Inc Stock Analysis and ForecastMomentum Trading Signals & Fast Profit Trading Tips - earlytimes.in
Olema Pharmaceuticals (NASDAQ:OLMA) Hits New 12-Month HighTime to Buy? - MarketBeat
Olema Oncology’s Stock Surge: Analyze Now? - timothysykes.com
Olema Oncology (OLMA) Sees Positive Surge in Stock Price - GuruFocus
Olema Pharmaceuticals Stock Surges Amid Analyst Optimism - TipRanks
Research Analysts Offer Predictions for OLMA FY2025 Earnings - MarketBeat
Lifesci Capital Has Positive Outlook of OLMA FY2025 Earnings - MarketBeat
Birchview Capital LP Invests $571,000 in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Citigroup maintains Olema Pharmaceuticals (OLMA) buy recommendation - MSN
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $48.00 - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Price Target Raised to $60.00 - MarketBeat
OLMA Stock: Citigroup Raises Price Target to $60, Maintains Buy - GuruFocus
Olema Pharmaceuticals (OLMA): HC Wainwright & Co. Raises Price T - GuruFocus
Olema Oncology (OLMA) Price Target Raised by Citi Amid Positive Trial Data - GuruFocus
Olema Pharmaceuticals (OLMA): Reassessing Valuation After Roche’s Phase 3 SERD Success Boosts Palazestrant Expectations - Sahm
Oppenheimer Raises Price Target for Olema Pharmaceuticals (OLMA) to $48 | OLMA Stock News - GuruFocus
OLMA: Goldman Sachs Raises Price Target to $38 on Maintained Buy Rating | OLMA Stock News - GuruFocus
The Goldman Sachs Group Issues Positive Forecast for Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 6% Following Analyst Upgrade - MarketBeat
Olema Pharmaceuticals Inc Azioni (OLMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):